Additionally, SNAT1 overexpression increases the phosphorylation level of Akt (p-Akt) and mTOR (p-mTOR) in osteosarcoma [13], breast cancer [14], and hepatocellular carcinoma (HCC) [15]. Here, MTOR is linked to osteosarcoma.